Antidiabetic...

Details Antidiabetic... Antidiabetic...

2008-01-15

2008-01-15

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S043000, C514S045000, C514S046000, C514S047000, C514S866000, C536S026100, C536S026120, C536S026130, C536S026210, C536S026260

Reexamination Certificate

active

07319093

ABSTRACT:
2-Substituted-5′-O-(1-boranotriphosphate)adenosine derivatives having at position 2 a radical R1 selected from the group consisting of H; halogen; O-hydrocarbyl; S-hydrocarbyl; NR3R4; and hydrocarbyl optionally substituted by halogen, CN, SCN, NO2, OR3, SR3 or NR3R4; wherein R3 and R4 are each independently H or hydrocarbyl or R3 and R4 together with the nitrogen atom to which they are attached form a saturated or unsaturated heterocyclic ring optionally containing 1-2 further heteroatoms selected from oxygen, nitrogen and sulfur, and pharmaceutically acceptable salts or diastereoisomers thereof or a mixture of diastereoisomers, are useful for treatment of type 2 diabetes.

REFERENCES:
patent: 5143907 (1992-09-01), Spielvogel et al.
patent: 5260427 (1993-11-01), Spielvogel et al.
patent: 5434143 (1995-07-01), Spielvogel et al.
patent: 5547942 (1996-08-01), Rapaport
patent: 5986086 (1999-11-01), Brush et al.
patent: WO 01/51490 (2001-07-01), None
patent: WO 03/008432 (2003-01-01), None
He et al. (“Synthesis and Separation of Diastereomers of Ribonucleoside 5′-(α-P-Borano)triphosphates”, J. Org. Chem., vol. 63. pp. 5769-5773, 1998).
He et al., “Synthesis and Separation of Diastereomers of Ribonucleoside 5′-(α-P-Borano) Triphosphates,” J. Org. Chem. 63:5769-5773, 1998.
Kozarich et al., “Ribonucleoside Phosphates via Phosphorimidazolidate Intermediates. Synthesis of Pseudoadenosine 5′-Triphosphate,” Biochemistry 12:4458-4463, 1973.
Fischer et al., “2-Thioether 5′-0-(1-Thiotriphosphate) Adenosine Derivatives as New Insulin Secretagogues Acting Through P2Y-Receptors,” J. Med. Chem. 42:3636-3646, 1999.
Hall et al., “Hypolipidemic Activity of Boronated Nucleosides and Nucleotides in Rodents,” Biomed. & Pharmacother. 47:79-87, 1993.
Hillaire-Buys et al., “Purinergic Receptors on Insulin-Secreting Cells,” Fundam. Clin. Pharmacol. 8:117-127, 1994.
Supplementary Partial European Search Report from corresponding European Application No. EP 02 77 7766 dated Sep. 5, 2005.

Affiliated with

Also associated with

Rating

Antidiabetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antidiabetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidiabetic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2808520